HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer procoagulant in serum of rats during development of experimental epithelioma.

Abstract
The activity of cancer procoagulant (CP) during the development of Guérin epithelioma was studied in the blood of Wistar rats. Blood was collected from the carotid artery and, after clotting, proteins adsorbing on aluminum hydroxide were removed from the serum. Then procoagulant activity was determined in the test system without factor VII by means of substrate S-2222 specific for factor Xa. A statistically significant increase in the activity of CP in serum was detected, coinciding with the period of intensive tumor growth (15th-25th day of disease).
AuthorsW Mielicki, R Wierzbicki
JournalInternational journal of cancer (Int J Cancer) Vol. 45 Issue 1 Pg. 125-6 (Jan 15 1990) ISSN: 0020-7136 [Print] United States
PMID2298496 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Blood Coagulation Factors
  • Neoplasm Proteins
  • Cysteine Endopeptidases
  • cancer procoagulant
Topics
  • Animals
  • Biomarkers, Tumor (blood)
  • Blood Coagulation Factors (analysis)
  • Carcinoma (blood)
  • Cysteine Endopeptidases (blood)
  • Female
  • Methods
  • Neoplasm Proteins
  • Neoplasm Transplantation
  • Rats
  • Rats, Inbred Strains
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: